Frequencies for first 10,000 rows of drugcl1 variable in namcs1994 dataset : drug class | for | medication | #1 | Freq. Percent Cum. ------------+----------------------------------- | 2,383 23.83 23.83 0100 | 1 0.01 23.84 0117 | 22 0.22 24.06 0119 | 6 0.06 24.12 0120 | 4 0.04 24.16 0281 | 2 0.02 24.18 0346 | 574 5.74 29.92 0347 | 332 3.32 33.24 0348 | 284 2.84 36.08 0350 | 68 0.68 36.76 0352 | 12 0.12 36.88 0353 | 86 0.86 37.74 0354 | 81 0.81 38.55 0355 | 54 0.54 39.09 0356 | 4 0.04 39.13 0358 | 26 0.26 39.39 0388 | 44 0.44 39.83 0408 | 62 0.62 40.45 0409 | 40 0.40 40.85 0411 | 2 0.02 40.87 0501 | 81 0.81 41.68 0502 | 85 0.85 42.53 0503 | 231 2.31 44.84 0504 | 26 0.26 45.10 0506 | 563 5.63 50.73 0507 | 202 2.02 52.75 0509 | 6 0.06 52.81 0626 | 19 0.19 53.00 0627 | 101 1.01 54.01 0628 | 41 0.41 54.42 0630 | 234 2.34 56.76 0631 | 38 0.38 57.14 0632 | 5 0.05 57.19 0789 | 138 1.38 58.57 0874 | 182 1.82 60.39 0875 | 29 0.29 60.68 0876 | 24 0.24 60.92 0877 | 35 0.35 61.27 0912 | 77 0.77 62.04 0913 | 102 1.02 63.06 0914 | 3 0.03 63.09 0915 | 47 0.47 63.56 0916 | 2 0.02 63.58 1000 | 3 0.03 63.61 1032 | 212 2.12 65.73 1033 | 18 0.18 65.91 1034 | 120 1.20 67.11 1035 | 5 0.05 67.16 1036 | 215 2.15 69.31 1037 | 87 0.87 70.18 1040 | 61 0.61 70.79 1041 | 1 0.01 70.80 1180 | 327 3.27 74.07 1181 | 5 0.05 74.12 1200 | 27 0.27 74.39 1264 | 14 0.14 74.53 1265 | 284 2.84 77.37 1371 | 8 0.08 77.45 1372 | 5 0.05 77.50 1373 | 97 0.97 78.47 1374 | 41 0.41 78.88 1400 | 14 0.14 79.02 1479 | 13 0.13 79.15 1566 | 7 0.07 79.22 1567 | 1 0.01 79.23 1568 | 83 0.83 80.06 1569 | 9 0.09 80.15 1670 | 13 0.13 80.28 1671 | 38 0.38 80.66 1700 | 14 0.14 80.80 1720 | 419 4.19 84.99 1723 | 16 0.16 85.15 1724 | 540 5.40 90.55 1725 | 12 0.12 90.67 1860 | 10 0.10 90.77 1862 | 1 0.01 90.78 1863 | 9 0.09 90.87 1940 | 154 1.54 92.41 1941 | 98 0.98 93.39 1943 | 118 1.18 94.57 1944 | 145 1.45 96.02 2000 | 262 2.62 98.64 2087 | 135 1.35 99.99 2095 | 1 0.01 100.00 ------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 28 Mar 2016